Catheter Research Development vs Cost Of Revenue Analysis
VTAK Stock | 0.35 0.02 5.41% |
Catheter Precision financial indicator trend analysis is way more than just evaluating Catheter Precision prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Catheter Precision is a good investment. Please check the relationship between Catheter Precision Research Development and its Cost Of Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.
Research Development vs Cost Of Revenue
Research Development vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Catheter Precision Research Development account and Cost Of Revenue. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Catheter Precision's Research Development and Cost Of Revenue is 0.15. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Catheter Precision, assuming nothing else is changed. The correlation between historical values of Catheter Precision's Research Development and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Catheter Precision are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Research Development i.e., Catheter Precision's Research Development and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | 0.15 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Research Development
Cost Of Revenue
Cost of Revenue is found on Catheter Precision income statement and represents the costs associated with goods and services Catheter Precision provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most indicators from Catheter Precision's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Catheter Precision current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.At this time, Catheter Precision's Selling General Administrative is quite stable compared to the past year. Discontinued Operations is expected to rise to about 2.6 M this year, although Enterprise Value Multiple will most likely fall to (1.32).
2021 | 2023 | 2024 (projected) | Interest Expense | 3.1M | 3.5M | 3.7M | Depreciation And Amortization | 1.6M | 2.1M | 1.3M |
Catheter Precision fundamental ratios Correlations
Click cells to compare fundamentals
Catheter Precision Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Catheter Precision fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 44.1M | 33.4M | 21.0M | 16.8M | 30.7M | 32.6M | |
Short Long Term Debt Total | 3.5M | 4.9M | 2.3M | 124.2K | 372K | 353.4K | |
Other Current Liab | 2.6M | 4.4M | 4.1M | 7.5M | 1.7M | 3.3M | |
Total Current Liabilities | 6.8M | 7.8M | 5.4M | 7.6M | 2.5M | 2.3M | |
Total Stockholder Equity | 33.2M | 21.1M | 13.7M | 9.3M | 21.2M | 21.6M | |
Property Plant And Equipment Net | 7.9M | 5.7M | 3.9M | 145.0K | 249K | 236.6K | |
Current Deferred Revenue | 1.7M | 1.7M | 2.0M | 1.8M | 2.1M | 2.0M | |
Net Debt | (11.1M) | (19.0M) | (12.8M) | (15.7M) | (3.2M) | (3.4M) | |
Retained Earnings | (117.2M) | (153.2M) | (178.3M) | (205.1M) | (275.7M) | (261.9M) | |
Accounts Payable | 1.5M | 471K | 988K | 92K | 464K | 557.1K | |
Cash | 14.6M | 23.9M | 15.0M | 15.9M | 3.6M | 3.4M | |
Non Current Assets Total | 8.1M | 5.8M | 4.0M | 145.0K | 26.6M | 27.9M | |
Non Currrent Assets Other | 196K | 123K | 36K | 8K | 7.2K | 6.8K | |
Cash And Short Term Investments | 30.6M | 23.9M | 15.0M | 15.9M | 3.6M | 3.4M | |
Net Receivables | 786K | 24K | 21K | 75.6K | 137K | 130.2K | |
Common Stock Shares Outstanding | 10.5K | 34.0K | 101K | 1.0M | 5.5M | 5.8M | |
Liabilities And Stockholders Equity | 44.1M | 33.4M | 21.0M | 16.8M | 30.7M | 32.6M | |
Non Current Liabilities Total | 4.1M | 4.5M | 2.0M | 247.0K | 7.1M | 3.9M | |
Inventory | 2.8M | 2.2M | 986K | 52.4K | 44K | 41.8K | |
Other Current Assets | 1.9M | 2.8M | 1.0M | 977K | 415K | 394.3K | |
Other Stockholder Equity | 150.3M | 174.3M | 191.9M | 214.4M | 296.9M | 163.7M | |
Total Liab | 10.9M | 12.3M | 7.4M | 7.6M | 9.5M | 8.0M | |
Total Current Assets | 36M | 27.6M | 17.1M | 16.8M | 4.2M | 4.0M | |
Short Term Debt | 611K | 1.0M | 283K | 36.7K | 275K | 361.2K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 30.61 | Revenue Per Share 0.604 | Quarterly Revenue Growth (0.03) | Return On Assets (0.22) | Return On Equity (0.50) |
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.